Corey N Martin1, Zhour Barnawi2, Elizabeth Chorvinsky3, Dhruv Pillai1, Meagan Gatti1, Maura E Collins4, Gina M Krakovsky5, Nancy M Bauman5, Sona Sehgal6, Dinesh K Pillai1,3. 1. Division of Pediatric Pulmonary and Sleep Medicine, Children's National Hospital, Washington, DC, USA. 2. Department of Pediatrics, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA. 3. Department of Genomics and Precision Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA. 4. Department of Hearing and Speech, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA. 5. Department of Otolaryngology-Head and Neck Surgery, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA. 6. Division of Pediatric Gastroenterology, Children's National Hospital, Washington, DC, USA.
Abstract
OBJECTIVE: To assess the association between commonly obtained endoscopic and serologic data and bronchoalveolar lavage pepsin assay (BAL) results in children with chronic cough. STUDY DESIGN: We performed a retrospective chart review of 72 children with a BAL pepsin obtained through our Aerodigestive Center over an 18-month period. BAL outcomes include evidence of viral, bacterial, or fungal infection, presence of lipid-laden macrophages, and cytology (eosinophils, neutrophils, and lymphocytes). Gastrointestinal outcomes include esophagogastroduodenoscopy (EGD) and pH impedance probe findings. Other characteristics include serum eosinophils, neutrophils, and lymphocytes; spirometry; FeNO; and IgE. RESULTS: Seventy-two patients underwent BAL pepsin testing. Median age was 4.9 years, 30.6% had severe persistent asthma, and 59.2% were on reflux medication. There was an association between positive BAL pepsin assay and positive viral panel (p = .002) or fungal culture (p = .027). No significant association found between positive BAL bacterial culture; BAL cytology; the presence of BAL lipid-laden macrophages; IgE; spirometry; FeNO; CBC neutrophil, eosinophil, or lymphocytes; pH impedance testing parameters; or EGD pathology. CONCLUSIONS: BAL pepsin is associated with a positive BAL viral PCR or fungal culture. Lack of correlation between pepsin-positivity and pH-impedance parameters or EGD pathology suggests microaspiration may be due to an acute event (such as a respiratory infection) rather than chronic gastroesophageal reflux disease. This may be especially true in the presence of a positive viral panel or fungal culture when a BAL pepsin is obtained.
OBJECTIVE: To assess the association between commonly obtained endoscopic and serologic data and bronchoalveolar lavage pepsin assay (BAL) results in children with chronic cough. STUDY DESIGN: We performed a retrospective chart review of 72 children with a BAL pepsin obtained through our Aerodigestive Center over an 18-month period. BAL outcomes include evidence of viral, bacterial, or fungal infection, presence of lipid-laden macrophages, and cytology (eosinophils, neutrophils, and lymphocytes). Gastrointestinal outcomes include esophagogastroduodenoscopy (EGD) and pH impedance probe findings. Other characteristics include serum eosinophils, neutrophils, and lymphocytes; spirometry; FeNO; and IgE. RESULTS: Seventy-two patients underwent BAL pepsin testing. Median age was 4.9 years, 30.6% had severe persistent asthma, and 59.2% were on reflux medication. There was an association between positive BAL pepsin assay and positive viral panel (p = .002) or fungal culture (p = .027). No significant association found between positive BAL bacterial culture; BAL cytology; the presence of BAL lipid-laden macrophages; IgE; spirometry; FeNO; CBC neutrophil, eosinophil, or lymphocytes; pH impedance testing parameters; or EGD pathology. CONCLUSIONS: BAL pepsin is associated with a positive BAL viral PCR or fungal culture. Lack of correlation between pepsin-positivity and pH-impedance parameters or EGD pathology suggests microaspiration may be due to an acute event (such as a respiratory infection) rather than chronic gastroesophageal reflux disease. This may be especially true in the presence of a positive viral panel or fungal culture when a BAL pepsin is obtained.
Authors: Marcin Grabowski; Ahmad Kasran; Sven Seys; Ans Pauwels; Wojciech Medrala; Lieven Dupont; Bernard Panaszek; Dominique Bullens Journal: Respir Med Date: 2011-05-17 Impact factor: 3.415
Authors: Zhaoping He; Robert C O'Reilly; Laura Bolling; Sam Soundar; Mansi Shah; Steven Cook; Richard J Schmidt; Esa Bloedon; Devendra I Mehta Journal: Otolaryngol Head Neck Surg Date: 2007-07 Impact factor: 3.497
Authors: Steven Shay; Radu Tutuian; Daniel Sifrim; Marcelo Vela; James Wise; Nagammapudur Balaji; Xin Zhang; Talal Adhami; Joseph Murray; Jeffrey Peters; Donald Castell Journal: Am J Gastroenterol Date: 2004-06 Impact factor: 10.864
Authors: Ronny M Schnabel; Catharina F Linssen; Nele Guion; Walther N van Mook; Dennis C Bergmans Journal: Open Forum Infect Dis Date: 2014-05-27 Impact factor: 3.835